Literature DB >> 16410346

The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

Neil J Perkins1, Enrique F Schisterman.   

Abstract

The use of biomarkers is of ever-increasing importance in clinical diagnosis of disease. In practice, a cutpoint is required for dichotomizing naturally continuous biomarker levels to distinguish persons at risk of disease from those who are not. Two methods commonly used for establishing the "optimal" cutpoint are the point on the receiver operating characteristic curve closest to (0,1) and the Youden index, J. Both have sound intuitive interpretations--the point closest to perfect differentiation and the point farthest from none, respectively--and are generalizable to weighted sensitivity and specificity. Under the same weighting of sensitivity and specificity, these two methods identify the same cutpoint as "optimal" in certain situations but different cutpoints in others. In this paper, the authors examine situations in which the two criteria agree or disagree and show that J is the only "optimal" cutpoint for given weighting with respect to overall misclassification rates. A data-driven example is used to clarify and demonstrate the magnitude of the differences. The authors also demonstrate a slight alteration in the (0,1) criterion that retains its intuitive meaning while resulting in consistent agreement with J. In conclusion, the authors urge that great care be taken when establishing a biomarker cutpoint for clinical use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410346      PMCID: PMC1444894          DOI: 10.1093/aje/kwj063

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

Review 1.  Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

Authors:  M Greiner; D Pfeiffer; R D Smith
Journal:  Prev Vet Med       Date:  2000-05-30       Impact factor: 2.670

2.  Adjusting the generalized ROC curve for covariates.

Authors:  Enrique F Schisterman; David Faraggi; Benjamin Reiser
Journal:  Stat Med       Date:  2004-11-15       Impact factor: 2.373

3.  The Youden Index and the optimal cut-point corrected for measurement error.

Authors:  Neil J Perkins; Enrique F Schisterman
Journal:  Biom J       Date:  2005-08       Impact factor: 2.207

4.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

5.  Receiver operating characteristic studies and measurement errors.

Authors:  M Coffin; S Sukhatme
Journal:  Biometrics       Date:  1997-09       Impact factor: 2.571

6.  TBARS and cardiovascular disease in a population-based sample.

Authors:  E F Schisterman; D Faraggi; R Browne; J Freudenheim; J Dorn; P Muti; D Armstrong; B Reiser; M Trevisan
Journal:  J Cardiovasc Risk       Date:  2001-08

Review 7.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

8.  Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality.

Authors:  T Sharir; D S Berman; P B Waechter; J Areeda; P B Kavanagh; J Gerlach; X Kang; G Germano
Journal:  J Nucl Med       Date:  2001-11       Impact factor: 10.057

9.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

10.  DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.

Authors:  Ru Chen; Peter S Rabinovitch; David A Crispin; Mary J Emond; Kent M Koprowicz; Mary P Bronner; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more
  465 in total

1.  Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.

Authors:  Xia Li; Richard G Abramson; Lori R Arlinghaus; Hakmook Kang; Anuradha Bapsi Chakravarthy; Vandana G Abramson; Jaime Farley; Ingrid A Mayer; Mark C Kelley; Ingrid M Meszoely; Julie Means-Powell; Ana M Grau; Melinda Sanders; Thomas E Yankeelov
Journal:  Invest Radiol       Date:  2015-04       Impact factor: 6.016

2.  Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.

Authors:  Bruce J Trock; Michelle J Brotzman; Leslie A Mangold; Joseph W Bigley; Jonathan I Epstein; David McLeod; Eric A Klein; J Stephen Jones; Songbai Wang; Theresa McAskill; Jyoti Mehrotra; Bhargavi Raghavan; Alan W Partin
Journal:  BJU Int       Date:  2011-11-11       Impact factor: 5.588

3.  Comparison of reliability and responsiveness of patient-reported clinical outcome measures in knee osteoarthritis rehabilitation.

Authors:  Valerie J Williams; Sara R Piva; James J Irrgang; Chad Crossley; G Kelley Fitzgerald
Journal:  J Orthop Sports Phys Ther       Date:  2012-03-08       Impact factor: 4.751

4.  Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis.

Authors:  Kengo Tomita; Toshiaki Teratani; Hirokazu Yokoyama; Takahiro Suzuki; Rie Irie; Hirotoshi Ebinuma; Hidetsugu Saito; Ryota Hokari; Soichiro Miura; Toshifumi Hibi
Journal:  Dig Dis Sci       Date:  2011-04-23       Impact factor: 3.199

Review 5.  The validation of screening tests: meet the new screen same as the old screen?

Authors:  Blase Gambino
Journal:  J Gambl Stud       Date:  2012-12

6.  Accuracy of Blood Pressure-to-Height Ratio to Define Elevated Blood Pressure in Children and Adolescents: The CASPIAN-IV Study.

Authors:  Roya Kelishadi; Maryam Bahreynian; Ramin Heshmat; Mohammad Esmail Motlagh; Shirin Djalalinia; Fatemeh Naji; Gelayol Ardalan; Hamid Asayesh; Mostafa Qorbani
Journal:  Pediatr Cardiol       Date:  2015-11-11       Impact factor: 1.655

7.  High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.

Authors:  Amandine Crombé; François Le Loarer; François Cornelis; Eberhardt Stoeckle; Xavier Buy; Sophie Cousin; Antoine Italiano; Michèle Kind
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

8.  Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors.

Authors:  Wen Tan; Hu Mei; Li Chao; Tengfei Liu; Xianchao Pan; Mao Shu; Li Yang
Journal:  J Comput Aided Mol Des       Date:  2013-12-10       Impact factor: 3.686

9.  Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.

Authors:  Takuya Koie; Koji Mitsuzuka; Takahiro Yoneyama; Shintaro Narita; Sadafumi Kawamura; Yasuhiro Kaiho; Norihiko Tsuchiya; Tatsuo Tochigi; Tomonori Habuchi; Yoichi Arai; Chikara Ohyama; Tohru Yoneyama; Yuki Tobisawa
Journal:  Int J Clin Oncol       Date:  2014-04-29       Impact factor: 3.402

10.  Novel Scoring System for Prediction of Cardiac Syndrome X in Women with Typical Angina and a Positive Exercise Tolerance Test.

Authors:  Farzad Masoudkabir; Ali Vasheghani-Farahani; Elham Hakki; Hamidreza Poorhosseini; Saeed Sadeghian; Seyed Hesameddin Abbasi; Shahram Bahmanyar; Seyed Ebrahim Kassaian
Journal:  Tex Heart Inst J       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.